NIH Awards Grant to FreshAir

Lebanon, NH – FreshAir, a developer of sensors to detect and alert for hazardous chemicals, has been awarded a Fast-Track Phase II grant totaling over $1.2 million from the National Institute on Drug Abuse, part of the National Institutes of Health (NIH). The 18-month grant will support development of effective vaping sensors for use in schools and other environments.

“We are accelerating the development of our sensors specific to the molecules released during e-cigarette vaping,” said Joseph BelBruno, chief technology officer of FreshAir.

The company offers technology to monitor for, immediately detect, and scientifically prove tobacco smoking and marijuana smoking.